Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 37, Pages 13373-13378
Publisher
Proceedings of the National Academy of Sciences
Online
2014-09-05
DOI
10.1073/pnas.1404848111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma
- (2013) I. Ben-Batalla et al. BLOOD
- Targeting the Hepatocyte Growth Factor/c-Met Signaling Pathway in Renal Cell Carcinoma
- (2013) Lauren C. Harshman et al. CANCER JOURNAL
- HIF1α and HIF2α independently activate SRC to promote melanoma metastases
- (2013) Sara C. Hanna et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma
- (2013) Z. Dong et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- First Axl inhibitor enters clinical trials
- (2013) Cormac Sheridan NATURE BIOTECHNOLOGY
- A liver Hif-2α–Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition
- (2013) Kevin Wei et al. NATURE MEDICINE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Axl is essential for VEGF-A-dependent activation of PI3K/Akt
- (2012) Guo-Xiang Ruan et al. EMBO JOURNAL
- Pathways and targets in hepatocellular carcinoma
- (2012) Amanda Psyrri et al. Expert Review of Anticancer Therapy
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
- (2012) Sakari Vanharanta et al. NATURE MEDICINE
- Treatment selection in metastatic renal cell carcinoma: expert consensus
- (2012) Bernard Escudier et al. Nature Reviews Clinical Oncology
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- HGF-independent potentiation of EGFR action by c-Met
- (2011) A M Dulak et al. ONCOGENE
- A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
- (2011) N. Suwaki et al. Science Translational Medicine
- AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
- (2010) E. B. Rankin et al. CANCER RESEARCH
- Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
- (2010) Rachel MA Linger et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
- (2009) S. Loges et al. BLOOD
- Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival
- (2009) A. Gustafsson et al. CLINICAL CANCER RESEARCH
- Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1 Enhances Hypoxic Gene Expression and Tumor Growth
- (2009) A. J. Krieg et al. MOLECULAR AND CELLULAR BIOLOGY
- Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
- (2009) Anna Gustafsson et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now